|
| Press Releases |
|
 |
|
| Tuesday, July 9, 2019 |
|
|
羚邦集团获中国国际动漫游戏博览会2019颁发「最具商业价值IP奖」 |
优质媒体内容的领先发行商羚邦集团有限公司（「羚邦集团」或「集团」，股份代号：2230.HK）今天宣布获中国国际动漫游戏博览会2019颁发「最具商业价值IP奖」，以表扬集团的成就及对中国动漫行业所作出的贡献。
more info >> |
|
|
羚邦集團獲中國國際動漫遊戲博覽會2019頒發「最具商業價值IP獎」 |
優質媒體內容的領先發行商羚邦集團有限公司（「羚邦集團」或「集團」，股份代號：2230.HK）今天宣佈獲中國國際動漫遊戲博覽會2019頒發「最具商業價值IP獎」，以表揚集團的成就及對中國動漫行業所作出的貢獻。
more info >> |
|
|
Medialink granted Best Commercial Value IP Award By CCG EXPO 2019 |
Medialink Group Limited ("Medialink" or the "Group", stock code: 2230.HK), a leading distributor of quality media content, announced today that it was granted the Best Commercial Value IP Award by China International Cartoon & Game Expo ("CCG EXPO") 2019, in recognition of the Groups success and contribution to the PRC animation industry.
more info >> |
|
| Friday, June 28, 2019 |
|
|
羚邦集团公布2018/19年全年业绩 |
羚邦集团有限公司(「羚邦集团」或「集团」，股份代号：2230.HK)，优质媒体内容的领先发行商及按2017年收益计中国最大的日本动画发行商，今天宣布截至2019年3月31日止年度的全年业绩。此乃集团于2019年5月在香港联合交易所有限公司 (「联交所」) 主板上市后首份全年业绩。
more info >> |
|
|
羚邦集團公佈2018/19年全年業績 |
| 羚邦集團有限公司(「羚邦集團」或「集團」，股份代號：2230.HK)，優質媒體內容的領先發行商及按2017年收益計中國最大的日本動畫發行商，今天宣佈截至2019年3月31日止年度的全年業績。此乃集團於2019年5月在香港聯合交易所有限公司 (「聯交所」) 主板上市後首份全年業績。 more info >> |
|
|
Medialink Announces 2018/19 Annual Results |
| Medialink Group Limited (2230.HK), a leading distributor of quality media content and PRC's largest Japanese animation distributor based on revenue in 2017, announced today its annual results for the year ended 31 March 2019 - the Group's first annual results since its listing on the Main Board of The Stock Exchange of Hong Kong (HKEX) in May 2019. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
